Document is current
Any future updates will be listed below
-
Authors
Sugimoto, Naomi
Morimasa, Mika
Misawa, Hidetoshi
Matsuoka, Nobushige
Sato, Yurami
Yamaguchi, Hiromi
Hiraiwa, Tetsuya
Yamashita, Natsuno
Hoshino, Akira
Kawai, Masanori
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 11 September 2025
First Online: 24 September 2025
Declarations
:
: NS, MM, HM, NM, HY, TH, NY, AH, and MK are employees at Pfizer R&D Japan. YS is an employee at Pfizer Japan Inc.. All authors may hold stock in Pfizer Inc., New York.
: The study was carried out in compliance with the principles of the Declaration of Helsinki, and the study protocol was approved by the external ethics committee in Japan Conference of Clinical Research (non-profit organization) in November 2022. Written informed consent was obtained from all participants before enrolment. Participants’ data including those obtained through ePRO were encrypted and stored on a server by Medidata Solutions, Inc., and accessible only to those who have specific privilege.
